Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

CLINICAL TRIALS

  • Open Access
    Five-year Efficacy and Safety of Tocilizumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Methotrexate- and Biologic-naive or Free of Methotrexate for 6 Months: the AMBITION Study
    Graeme Jones, Thomas Wallace, Matthew J. McIntosh, Laura Brockwell, Juan J. Gómez-Reino and Anthony Sebba
    The Journal of Rheumatology February 1 2017, 44 (2) 142-146; DOI: https://doi.org/10.3899/jrheum.160287
  • You have access
    Optimal Strategies for Reporting Pain in Clinical Trials and Systematic Reviews: Recommendations from an OMERACT 12 Workshop
    Jason W. Busse, Susan J. Bartlett, Maxime Dougados, Bradley C. Johnston, Gordon H. Guyatt, John R. Kirwan, Kent Kwoh, Lara J. Maxwell, Andrew Moore, Jasvinder A. Singh, Randall Stevens, Vibeke Strand, Maria E. Suarez-Almazor, Peter Tugwell and George A. Wells
    The Journal of Rheumatology October 1 2015, 42 (10) 1962-1970; DOI: https://doi.org/10.3899/jrheum.141440
  • You have access
    Immunosuppressive Therapies for the Maintenance Treatment of Proliferative Lupus Nephritis: A Systematic Review and Network Metaanalysis
    Simon Yu Tian, Brian M. Feldman, Joseph Beyene, Patrick E. Brown, Elizabeth M. Uleryk and Earl D. Silverman
    The Journal of Rheumatology August 1 2015, 42 (8) 1392-1400; DOI: https://doi.org/10.3899/jrheum.141650
  • You have access
    Clinical Trials Perception in Rheumatology Patients: Experience from a Single Rheumatology Tertiary Center
    Coziana Ciurtin, Maria Leandro, Halina Fitz-Clarence, Hanh Nguyen, Stephen B. Walsh and David A. Isenberg
    The Journal of Rheumatology June 1 2015, 42 (6) 988-993; DOI: https://doi.org/10.3899/jrheum.141091
  • You have access
    Immunosuppressive Therapies for the Induction Treatment of Proliferative Lupus Nephritis: A Systematic Review and Network Metaanalysis
    Simon Yu Tian, Brian M. Feldman, Joseph Beyene, Patrick E. Brown, Elizabeth M. Uleryk and Earl D. Silverman
    The Journal of Rheumatology October 1 2014, 41 (10) 1998-2007; DOI: https://doi.org/10.3899/jrheum.140050
  • You have access
    How to Choose Core Outcome Measurement Sets for Clinical Trials: OMERACT 11 Approves Filter 2.0
    Maarten Boers, John R. Kirwan, Laure Gossec, Philip G. Conaghan, Maria-Antonietta D’Agostino, Clifton O. Bingham III, Peter M. Brooks, Robert Landewé, Lyn March, Lee Simon, Jasvinder A. Singh, Vibeke Strand, George A. Wells and Peter Tugwell
    The Journal of Rheumatology May 1 2014, 41 (5) 1025-1030; DOI: https://doi.org/10.3899/jrheum.131314
  • You have access
    Updating the OMERACT Filter at OMERACT 11
    John R. Kirwan, Maarten Boers and Peter Tugwell
    The Journal of Rheumatology May 1 2014, 41 (5) 975-977; DOI: https://doi.org/10.3899/jrheum.131306
  • You have access
    Toward a Generalized Framework of Core Measurement Areas in Clinical Trials: A Position Paper for OMERACT 11
    Maarten Boers, Leanne Idzerda, John R. Kirwan, Dorcas Beaton, Reuben Escorpizo, Annelies Boonen, Susan Magasi, Ian Sinha, Gerold Stucki and Peter Tugwell
    The Journal of Rheumatology May 1 2014, 41 (5) 978-985; DOI: https://doi.org/10.3899/jrheum.131307
  • You have access
    Can We Decide Which Outcomes Should Be Measured in Every Clinical Trial? A Scoping Review of the Existing Conceptual Frameworks and Processes to Develop Core Outcome Sets
    Leanne Idzerda, Tamara Rader, Peter Tugwell and Maarten Boers
    The Journal of Rheumatology May 1 2014, 41 (5) 986-993; DOI: https://doi.org/10.3899/jrheum.131308
  • You have access
    Updating the OMERACT Filter: Core Areas as a Basis for Defining Core Outcome Sets
    John R. Kirwan, Maarten Boers, Sarah Hewlett, Dorcas Beaton, Clifton O. Bingham III, Ernest Choy, Philip G. Conaghan, Maria-Antonietta D’Agostino, Maxime Dougados, Daniel E. Furst, Francis Guillemin, Laure Gossec, Désirée M. van der Heijde, Margreet Kloppenburg, Tore K. Kvien, Robert B.M. Landewé, Sarah L. Mackie, Eric L. Matteson, Philip J. Mease, Peter A. Merkel, Mikkel Ostergaard, Lesley Ann Saketkoo, Lee Simon, Jasvinder A. Singh, Vibeke Strand and Peter Tugwell
    The Journal of Rheumatology May 1 2014, 41 (5) 994-999; DOI: https://doi.org/10.3899/jrheum.131309

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire